Tempur Sealy shares plunged more than 23 percent intraday Wednesday after the mattress maker handed in a disappointing full-year sales guidance. » Read More
A flurry of Fed speakers, including the Fed chair, will keep markets busy Wednesday.
Nomura initiates coverage of Amazon with a buy rating.
The "Fast Money" traders looked for opportunities in consumer stocks after Nike's future orders disappointed Wall Street on Tuesday.
Mizuho just downgraded Twitter to underperform, citing extended valuations and skepticism over whether the social media company will be acquired.
Some of the names on the move ahead of the open.
Jim Cramer spoke with the CEO of Thor Industries following record sales of RVs on what could be steering growth.
Jim Cramer officially unveils his new acronym for red-hot growth stocks in the market.
Shares of Ligand Pharmaceuticals plunged 12 percent Tuesday after Amgen said its multiple myeloma drug, Kyprolis, did not outperform Takeda Pharmaceutical's Velcade in a late-stage study.
Steven DeSanctis, one of the most widely followed small-cap strategists on Wall Street, discusses his top investment themes in the space.
Credit Suisse downgrades J.M. Smucker, maker of Kibbles 'n Bits dog food and Milk-Bone treats, to neutral from outperform.
With the race for the White House tightening, markets could be in for a bumpy road ahead in the near term.
Shares of Avis Budget Group fell more than 8 percent on a volume spike, following comments made Tuesday about weaker European demand in August.
Investors are unusually nervous about the market right now, which is "one more reason we're bullish on equities," says Oppenheimer's Ari Wald.
Weatherford International Plc agreed to pay a $140 million penalty to settle charges that it inflated earnings using deceptive income tax accounting.
Rice Energy shares slid by more than 7 percent after buying Vantage Energy for about $2.7 billion, including debt.
Shares of Kite Pharma climbed 9 percent Tuesday after receiving positive clinical trial results for a non-Hodgkin's lymphoma treatment.
Get the best of CNBC in your inbox